Selected research
Industry Growth & Trends
Global Virus Bank Manufacturing Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Virus Bank Manufacturing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Virus Bank Manufacturing is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Virus Bank Manufacturing is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Virus Bank Manufacturing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Virus Bank Manufacturing market include Clean Cells, Sigma-Aldrich, ReciBioPharm, ViruSure, Cell and Gene, Naobios, TFBS Bioscience, Inc., Catalent Biologics and SK pharmteco, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Virus Bank Manufacturing market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Virus Bank Manufacturing market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Virus Bank Manufacturing market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Virus Bank Manufacturing.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Virus Bank Manufacturing market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Virus Bank Manufacturing Market by Company
Clean Cells
Sigma-Aldrich
ReciBioPharm
ViruSure
Cell and Gene
Naobios
TFBS Bioscience, Inc.
Catalent Biologics
SK pharmteco
Charles River Laboratories
SGS SA
Virus Bank Manufacturing Segment by Type
Master Virus Seeds Stocks
Working Virus Seeds Stocks
Virus Bank Manufacturing Segment by Application
Biological Vaccines
Gene Therapy
Others
Virus Bank Manufacturing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Virus Bank Manufacturing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Virus Bank Manufacturing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Virus Bank Manufacturing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Virus Bank Manufacturing companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Master Virus Seeds Stocks
- Working Virus Seeds Stocks
Applications
- Biological Vaccines
- Gene Therapy
- Others
Companies covered
- Clean Cells
- Sigma-Aldrich
- ReciBioPharm
- ViruSure
- Cell and Gene
- Naobios
- TFBS Bioscience, Inc.
- Catalent Biologics
- SK pharmteco
- Charles River Laboratories
- SGS SA
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Virus Bank Manufacturing Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Virus Bank Manufacturing Market Size by Region (2021-2032)
- 1.4.1 Global Virus Bank Manufacturing Market Size by Region (2021-2026)
- 1.4.2 Global Virus Bank Manufacturing Market Size by Region (2027-2032)
- 1.5 Key Regions Virus Bank Manufacturing Market Size (2021-2032)
- 1.5.1 North America Virus Bank Manufacturing Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Virus Bank Manufacturing Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Virus Bank Manufacturing Market Size Growth Rate (2021-2032)
- 1.5.4 South America Virus Bank Manufacturing Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Virus Bank Manufacturing Market Size Growth Rate (2021-2032)
2 Virus Bank Manufacturing Market by Type
- 2.1 Type Introduction
- 2.1.1 Master Virus Seeds Stocks
- 2.1.2 Working Virus Seeds Stocks
- 2.2 Global Virus Bank Manufacturing Market Size by Type
- 2.2.1 Global Virus Bank Manufacturing Market Size Overview by Type (2021-2032)
- 2.2.2 Global Virus Bank Manufacturing Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Virus Bank Manufacturing Market Size Forecasted by Type (2027-2032)
- 2.3 Global Virus Bank Manufacturing Market Size by Regions
- 2.3.1 North America Virus Bank Manufacturing Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Virus Bank Manufacturing Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Virus Bank Manufacturing Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Virus Bank Manufacturing Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Virus Bank Manufacturing Market Size Breakdown by Type (2021-2026)
3 Virus Bank Manufacturing Market by Application
- 3.1 Type Introduction
- 3.1.1 Biological Vaccines
- 3.1.2 Gene Therapy
- 3.1.3 Others
- 3.2 Global Virus Bank Manufacturing Market Size by Application
- 3.2.1 Global Virus Bank Manufacturing Market Size Overview by Application (2021-2032)
- 3.2.2 Global Virus Bank Manufacturing Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Virus Bank Manufacturing Market Size Forecasted by Application (2027-2032)
- 3.3 Global Virus Bank Manufacturing Market Size by Regions
- 3.3.1 North America Virus Bank Manufacturing Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Virus Bank Manufacturing Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Virus Bank Manufacturing Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Virus Bank Manufacturing Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Virus Bank Manufacturing Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Virus Bank Manufacturing Industry Trends
- 4.2 Virus Bank Manufacturing Industry Drivers
- 4.3 Virus Bank Manufacturing Industry Opportunities and Challenges
- 4.4 Virus Bank Manufacturing Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Virus Bank Manufacturing Revenue (2021-2026)
- 5.2 Global Virus Bank Manufacturing Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Virus Bank Manufacturing Key Company Headquarters & Area Served
- 5.4 Global Virus Bank Manufacturing Company, Product Type & Application
- 5.5 Global Virus Bank Manufacturing Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Virus Bank Manufacturing Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Virus Bank Manufacturing Players Market Share by Revenue in 2025
- 5.6.3 2025 Virus Bank Manufacturing Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Clean Cells
- 6.1.1 Clean Cells Company Information
- 6.1.2 Clean Cells Business Overview
- 6.1.3 Clean Cells Virus Bank Manufacturing Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Clean Cells Virus Bank Manufacturing Product Portfolio
- 6.1.5 Clean Cells Recent Developments
- 6.2 Sigma-Aldrich
- 6.2.1 Sigma-Aldrich Company Information
- 6.2.2 Sigma-Aldrich Business Overview
- 6.2.3 Sigma-Aldrich Virus Bank Manufacturing Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Sigma-Aldrich Virus Bank Manufacturing Product Portfolio
- 6.2.5 Sigma-Aldrich Recent Developments
- 6.3 ReciBioPharm
- 6.3.1 ReciBioPharm Company Information
- 6.3.2 ReciBioPharm Business Overview
- 6.3.3 ReciBioPharm Virus Bank Manufacturing Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 ReciBioPharm Virus Bank Manufacturing Product Portfolio
- 6.3.5 ReciBioPharm Recent Developments
- 6.4 ViruSure
- 6.4.1 ViruSure Company Information
- 6.4.2 ViruSure Business Overview
- 6.4.3 ViruSure Virus Bank Manufacturing Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 ViruSure Virus Bank Manufacturing Product Portfolio
- 6.4.5 ViruSure Recent Developments
- 6.5 Cell and Gene
- 6.5.1 Cell and Gene Company Information
- 6.5.2 Cell and Gene Business Overview
- 6.5.3 Cell and Gene Virus Bank Manufacturing Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Cell and Gene Virus Bank Manufacturing Product Portfolio
- 6.5.5 Cell and Gene Recent Developments
- 6.6 Naobios
- 6.6.1 Naobios Company Information
- 6.6.2 Naobios Business Overview
- 6.6.3 Naobios Virus Bank Manufacturing Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Naobios Virus Bank Manufacturing Product Portfolio
- 6.6.5 Naobios Recent Developments
- 6.7 TFBS Bioscience, Inc.
- 6.7.1 TFBS Bioscience, Inc. Company Information
- 6.7.2 TFBS Bioscience, Inc. Business Overview
- 6.7.3 TFBS Bioscience, Inc. Virus Bank Manufacturing Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 TFBS Bioscience, Inc. Virus Bank Manufacturing Product Portfolio
- 6.7.5 TFBS Bioscience, Inc. Recent Developments
- 6.8 Catalent Biologics
- 6.8.1 Catalent Biologics Company Information
- 6.8.2 Catalent Biologics Business Overview
- 6.8.3 Catalent Biologics Virus Bank Manufacturing Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Catalent Biologics Virus Bank Manufacturing Product Portfolio
- 6.8.5 Catalent Biologics Recent Developments
- 6.9 SK pharmteco
- 6.9.1 SK pharmteco Company Information
- 6.9.2 SK pharmteco Business Overview
- 6.9.3 SK pharmteco Virus Bank Manufacturing Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 SK pharmteco Virus Bank Manufacturing Product Portfolio
- 6.9.5 SK pharmteco Recent Developments
- 6.10 Charles River Laboratories
- 6.10.1 Charles River Laboratories Company Information
- 6.10.2 Charles River Laboratories Business Overview
- 6.10.3 Charles River Laboratories Virus Bank Manufacturing Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Charles River Laboratories Virus Bank Manufacturing Product Portfolio
- 6.10.5 Charles River Laboratories Recent Developments
- 6.11 SGS SA
- 6.11.1 SGS SA Company Information
- 6.11.2 SGS SA Business Overview
- 6.11.3 SGS SA Virus Bank Manufacturing Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 SGS SA Virus Bank Manufacturing Product Portfolio
- 6.11.5 SGS SA Recent Developments
7 North America
- 7.1 North America Virus Bank Manufacturing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Virus Bank Manufacturing Market Size by Country (2021-2026)
- 7.3 North America Virus Bank Manufacturing Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Virus Bank Manufacturing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Virus Bank Manufacturing Market Size by Country (2021-2026)
- 8.3 Europe Virus Bank Manufacturing Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Virus Bank Manufacturing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Virus Bank Manufacturing Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Virus Bank Manufacturing Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Virus Bank Manufacturing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Virus Bank Manufacturing Market Size by Country (2021-2026)
- 10.3 South America Virus Bank Manufacturing Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Virus Bank Manufacturing Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Virus Bank Manufacturing Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Virus Bank Manufacturing Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst